Is there a difference in inflammatory marker levels between CF patients who harbour sporadic and transmissible strains of Pseudomonas aeruginosa?

A. M. Jones, R. J. Bright-Thomas, L. Martin, A. McDowell, K. Moffitt, M. E. Dodd, J. S. Elborn, A. K. Webb

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationJournal of Cystic Fibrosis
PublisherEuropean Cystic Fibrosis Society
PagesS36-S36
Number of pages1
Publication statusPublished - Jun 2003
Event26th European Cystic Fibrosis Society Conference - Belfast, UK
Duration: 1 Jun 2003 → …

Conference

Conference26th European Cystic Fibrosis Society Conference
Period1/06/03 → …

Cite this

Jones, A. M., Bright-Thomas, R. J., Martin, L., McDowell, A., Moffitt, K., Dodd, M. E., Elborn, J. S., & Webb, A. K. (2003). Is there a difference in inflammatory marker levels between CF patients who harbour sporadic and transmissible strains of Pseudomonas aeruginosa? In Journal of Cystic Fibrosis (pp. S36-S36). European Cystic Fibrosis Society.